In all CML patients but one (patient #1) CBY1 reduced expression was associated with a significant increment in its SUMOylation compared to the HD pool (p<0.05 or less) (Fig 6C). Here, CBY1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.